Use of an Antiemetic to Shorten the Length of Labor in Nulliparous Women

• Status: Completed
• Trial end date: 2016-09-01
• Target enrollment: 0
• Participant gender: Female

Summary

Reducing the length of labor is a highly desirable goal of intrapartum care, both from a perspective of maternal and fetal well-being , and for the providers of the birth services. Avoiding a long , protracted labor entails shorter exposure to pain anxiety and stress and would translate into a major improvement in maternal satisfaction with the child birth experience.

The purpose of this study is to determine the effectiveness of metoclopramide for reducing the duration of spontaneous labor among nulliparous women managed according to a standard intrapartum protocol.

• Phase: Phase 4
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Ain Shams University
• Collaborators: Armed Forces Hospital, Southern Region, Khamis Mushayt, Saudi Arabia; Armed Forces Hospitals, Southern Region, Saudi Arabia
• Treatments: Antiemetics; Metoclopramide

Criteria

Inclusion Criteria:

• Primigravida

• Singleton pregnancy

• Term gestation i.e. 37- 42 weeks

• Sure reliable dates

• Vertex presentation, occipitoanterior position

• Spontaneous onset of labor

• Regular uterine contractions at every 5 min ,each lasting for 20 sec

• Cervical dilatation of 3-5cm

• With or without rupture of membranes

• No evidence of maternal or fetal distress

Exclusion Criteria:

• Mal-presentations

• Mal-positions

• Multifetal pregnancy

• Cephalopelvic disproportion

• history of cervical surgery or injury

• Hypersensitivity to metoclopramide